Clinical Trials

NCT02795052 | RECRUITING | NA
500 participants

Neurologic Stem Cell Treatment Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2016-06-30
Completion:
2027-07-31
Conditions
  • Neurologic Disorders
  • Nervous System Diseases
  • Neurodegenerative Diseases
  • Neurological Disorders
  • Stroke
  • Traumatic Brain Injury
  • Cadasil
  • Chronic Traumatic Encephalopathy
  • Cerebral Infarction
  • Cerebral Ischemia
  • Cerebral Stroke
  • Cerebral Hemorrhage
  • Parkinson
  • Multi-System Degeneration
  • MSA - Multiple System Atrophy
  • Progressive Supranuclear Palsy
  • ALS
  • Amyotrophic Lateral Sclerosis
  • Neuropathy
  • Diabetic Neuropathies
  • Alzheimer Disease
  • Dementia
  • Frontotemporal Dementia
  • Lewy Body Disease
  • Cognitive Impairment
  • Lewy Body Variant of Alzheimer Disease
Interventions
  • PROCEDURE
No Results Yet
NCT02520791 | ACTIVE_NOT_RECRUITING | PHASE1
21 participants

Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2016-09-13
Completion:
2024-12-18
Conditions
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Recurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3a Follicular Lymphoma
  • Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Recurrent Mycosis Fungoides
  • Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Refractory Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type
  • Refractory Grade 1 Follicular Lymphoma
  • Refractory Grade 2 Follicular Lymphoma
  • Refractory Grade 3a Follicular Lymphoma
  • Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
  • Stage IB Mycosis Fungoides AJCC v7
  • Stage II Mycosis Fungoides AJCC v7
  • Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage III Mycosis Fungoides AJCC v7
  • Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma
  • Stage IV Mycosis Fungoides AJCC v7
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT01750073 | COMPLETED | PHASE2
92 participants

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-26
Start Date:
2012-12-07
Completion:
2022-05-01
Conditions
  • Estrogen Receptor Negative
  • Estrogen Receptor Positive
  • HER2/Neu Negative
  • HER2/Neu Positive
  • Invasive Breast Carcinoma
  • Progesterone Receptor Negative
  • Progesterone Receptor Positive
  • Stage IA Breast Cancer
  • Stage II Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage III Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • OTHER
  • RADIATION
  • PROCEDURE
  • BIOLOGICAL
NCT07669805 | NOT_YET_RECRUITING | NA
50 participants

Social Prescribing for a Mindful Lifestyle

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-25
Start Date:
2026-07-01
Completion:
2028-12-31
Conditions
  • Depression and/or Anxiety in the Mild-to-moderate Range
  • Loneliness
  • Social Isolation
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page